Our findings indicate that fibrosis progression in steatotic liver disease is mediated by an interaction of environmental risk factors (obesity, insulin resistance, alcohol consumption) and genetic risk variants, such as PNPLA3 and TM6SF2, but not by genetic variants alone. Here, TM6SF2 is linked to obesity due to melanocortin 4 receptor deficiency.